Distribuzione geografica
Continente #
AF - Africa 240
NA - Nord America 186
AS - Asia 176
EU - Europa 123
Totale 725
Nazione #
CI - Costa d'Avorio 240
US - Stati Uniti d'America 186
SG - Singapore 160
CZ - Repubblica Ceca 38
DE - Germania 28
IE - Irlanda 21
UA - Ucraina 10
IT - Italia 9
FI - Finlandia 8
CN - Cina 7
ES - Italia 7
HK - Hong Kong 6
GB - Regno Unito 2
ID - Indonesia 1
IN - India 1
VN - Vietnam 1
Totale 725
Città #
Abidjan 240
New York 105
Singapore 71
Boardman 39
Brno 31
Dublin 21
Frankfurt am Main 21
West Jordan 14
Lappeenranta 8
Munich 7
Hong Kong 6
Olomouc 6
Córdoba 5
Casoria 3
Forest City 3
Beijing 2
Chicago 2
Huelva 2
Kunming 2
Salerno 2
Southwark 2
Campobasso 1
Civitacampomarano 1
Ho Chi Minh City 1
Huntsville 1
Malang 1
Milan 1
Prague 1
Pune 1
San Francisco 1
San Tammaro 1
Shanghai 1
Totale 603
Nome #
[Inhibitors of intra-cystic secretion: novel therapies in ADPKD (Autosomal Dominant Polycystic Kidney Disease)] 14
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 12
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 11
A gene and epigenetic combination therapy for liver cancer treatment 11
Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives 11
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 10
Adherence to Barcelona Clinic Liver Cancer guidelines in field-practice: results of Progetto Epatocarcinoma Campania 10
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 10
Characteristics and outcome of cryptogenic cirrhosis in Italy 9
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 9
Cryptogenic cirrhosis is associated with cardiometabolic and oncologic comorbidities and poor liver-related prognosis 9
[Next Generation Sequencing and ADPKD] 9
. Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis. 9
Sonoporation by microbubbles as gene therapy approach for liver cancer 9
A genic and epigenetic combination therapy for liver cancer 8
An atypical resentation of a parasitic infection, simulating abdominal expansive mass: a multidisciplinary case report 8
Angiogenesis inhibitors for the treatment of hepatocellular carcinoma 8
A clear case of portal hypertension: a logical consequence of liver cirrhosis? 8
An atypical presentation of a rare parasitic infection of Fasciola hepatica: a multidisciplinary case report. 8
A suspected infective endocarditis in patients with a history of chronic HCV infection 8
Twelve-week course of pIFN-a-2a/ribavirin is an optimized regimen for treatment of HCV genotype 2 but not genotype 3 non-cirrhotic patients with RVR 7
Adherence to AISF recommendations for integrated management of hepatocellular carcinoma in a real–world clinical practice 7
Antibiotic use and associated factors in a large sample of hospitalised older people 7
Editorial – Role of Highly Active Antiretroviral Therapy (HAART) for the COVID-19 treatment 6
Lactate in pleural and abdominal effusions 6
Mechanisms and clinical behavior of hepatocellular carcinoma in HBV and HCV infection and alcoholic and non-alcoholic fatty liver disease 6
Epigenetic and Genetic Keys to Fight HPV-Related Cancers 6
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 6
Ruolo patogenetico dell’adiponectina nella steatosi associata ad epatite C 6
L'indagine medico-nucleare delle masse timiche 6
Hepatocellular carcinoma in patients with cryptogenic and metabolic cirrhosis: Incidence, characteristics, risk factors and survival 6
Management of HBV infection in oncohematologic immunosuppressed patients: lamivudine prohylaxis and rescue therapy of occult HBV infection 6
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 6
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 6
Late HCC onset after DAAs therapy in patients with SVR: A type D ADR that requires a longer follow-up? 6
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 6
L'indagine medico-nucleare dei tumori del pancreas endocrino 6
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations 6
HCC recurrence after DAA treatment in HCV patients 5
Influence of antiviral therapy on liver stiffness evaluation in chronic hepatitis HBV patients in a real world setting: preliminary data in a multicentric study 5
Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register 5
Early changes of liver stiffness in HCV patients undergoing treatment with direct-acting antivirals (DDAs): a multicenter study 5
Late HCC onset after direct antiviral agents therapy in patients with sustained virological response: do we need to reconsider their efficacy according to long term follow-up? 5
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 5
Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 5
Different serological, molecular and cytokine profiles characterize active and inactive disease patients with chronic hepatitis B virus (HBV infection) 5
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 5
Hepatocellular carcinoma in HCV cirrhosis after viral clearance with direct acting antiviral therapy: preliminary evidence and possible meanings 5
Chronic Hepatitis C Virus Infection and Depression 5
Different serological, molecular and cytokine profiles characterize active and inactive disease in patients with chronic hepatitis B virus (HBV) infection 5
Hepatitis C virus eradication by direct antiviral agents improves carotid atherosclerosis in patients with advanced fibrosis/compensated cirrhosis 5
Steatosis is a determinant of fibrosis progression in chronic hepatitis C and is correlated both with body composition and viral factors 5
Angiogenesis inhibitors for the treatment of hepatocellular carcinoma 5
Influenza virus infections: clinical update, molecular biology, and therapeutic options 5
Hepatocellular carcinoma in patients with cryptogenic and metabolic cirrhosis: incidence, characteristics, risk factors and survival 5
HCV-related steatosis and risk of atherosclerosis 5
Late HCC onset after direct antiviral agents therapy in patients with sustained virological response: do we need to reconsider their efficacy according to long term follow-up? 4
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 4
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 4
Patterns of infectious in older patients acutely admitted to medical wards: data from the REPOSI register 4
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 4
Hepatic Steatosis And necro-Inflammatory Activity overestimate Liver Stiffness by Transient Elastography in Staging Liver Fibrosis in Chronic Hepatitis C 4
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 4
NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes 4
Hepatitis B virus reactivation after heart transplant: Incidence and clinical impact 4
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 4
Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study 4
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 4
Physician Attitudes and Perceptions of Complementary and Alternative Medicine (CAM): A Multicentre Italian Study 4
. Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics 4
A Controversial Case of a Double Hepatic Incidentaloma in a Male Patient with Kidney Failure 4
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 4
Cardiovascular benefits from gliflozins: Effects on endothelial function 4
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 4
Features of microvessel density (MVD) and angiogenesis inhibitors in therapeutic approach of hepatocellular carcinoma (HCC) 4
Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antivirals therapy. A prospective study 4
FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage 4
Influence of ITPase activity on decreases of hemoglobin during treatment with interferon-free DAA based and ribavirin in HCV related cirrhosis 4
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 4
HCV-related steatosis and risk of atherosclerosis 4
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 3
The importance of the thick ascending limb of Henle's loop in renal physiology and pathophysiology 3
Editorial - HCC in HCV patients and the direct acting antivirals: is there really a link? 3
The use of non selective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients 3
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment 3
Metformin Lactic Acidosis: should we still be afraid? 3
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosi 3
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 3
Predictors of in-hospital mortality of COVID-19 patients and the role of telemetry in an internal medicine ward during the third phase of the pandemic 3
Editorial: Tissue resonance interaction method: a challenge for the early and non-invasive diagnosis of solid cancers 3
Renal phenotype in bardet-biedl syndrome: A combined defect of urinary concentration and dilution is associated with defective urinary aqp2 and umod excretion 3
Role of tight glycemic control during acute coronary syndrome on CV outcome in type 2 diabetes 3
Metformin: An old drug against old age and associated morbidities 3
Distribution of allelic frequency of IL28B gene polymorphism is equal in patients with newly diagnosed HCV-infected and HCV-reinfection liver-transplanted recipients from the same geographical area 3
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 3
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 3
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 3
Transient elastography has a practical role in monitoring liver transplanted patients: preliminary results from experience in a real world setting 3
Percutaneous implant of Denver peritoneovenous shunt for treatment of refractory ascites. 3
Totale 550
Categoria #
all - tutte 15.254
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.254

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024365 0 0 0 0 2 164 12 49 5 17 20 96
2024/2025373 373 0 0 0 0 0 0 0 0 0 0 0
Totale 738